|Articles|August 6, 2019
Technology Matters: Next-Generation RNA-Based Diagnostics Improve Disease Detection
Advertisement
Recent advancements in nucleic acid amplification tests (NAATs) have enabled clinicians to diagnose patients with improved accuracy for important pathogens. But are clinicians impeded by common misconceptions about available tools, or even key differences between DNA and RNA?
This supplement accurately explains the science of RNA-based testing modalities and reviews methods and results of assays for Mycoplasma genitalium, bacterial vaginosis, vulvovaginal candidiasis, Trichomonas vaginalis, and human papillomavirus.
Disclosures:
References:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
2
Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals
3
Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage
4
Spotlighting the endometriosis, preeclampsia research gap in Black women, with Calbeth C. Alaribe, DMSc, MPH, PA-C
5